The Society For Women’s Health Research Welcomes New Board Member



Washington, D.C.  (September 22, 2015) — The Society for Women’s Health Research (SWHR®) is excited to announce the appointment of a new member to its Board of Directors. Joining the Board is Shontelle Dodson, PharmD, vice president of Medical Excellence within Medical Affairs, Global, at Astellas Pharma Inc.

“We are delighted to welcome Dr. Dodson to our Board of Directors,” said Phyllis Greenberger, MSW, president and CEO of SWHR. “Her extensive experience in the pharmaceutical and health care industries, clinical research, and real world data analysis and her involvement in developing and implementing medical and managed access strategies to support patient health will be a great asset to advancing our mission to transform women’s health.”

Dr. Dodson has extensive clinical and research experience in the healthcare and pharmaceutical industries.  After several years of service in direct patient care at the Department of Veterans Affairs, Dr. Dodson spent 11 years at Pfizer, Inc., in various leadership roles, serving as the leader of the U.S. Viagra Medical Team and as senior director, group leader supporting the Urology and Respiratory franchise.

Following her work with Pfizer, Dr. Dodson served as vice president, Medical Affairs at GTx, Inc., where she led the Phase 3 clinical development of a selective androgen receptor modulator for the prevention and treatment of muscle wasting in patients with cancer, including key economic and health outcomes assessments to support product utilization and valuation.

Under her leadership at Astellas, the Health Economics and Clinical Outcomes Research team in the Americas has pioneered multiple, innovative real world data projects, including two national registries in prostate cancer and overactive bladder, as well as partnered research with leading managed care and academic organizations.

She has received multiple awards for leadership and innovation during her career, including the National Healthcare Business Women’s Association Rising Star.  Dr. Dodson holds a doctor of pharmacy degree from Mercer University School of Pharmacy and completed a postdoctoral residency at the Department of Veterans Affairs Medical Center in Nashville, Tennessee.

“I am honored to join the Society for Women’s Health Research Board of Directors to lend my expertise, especially in clinical research and real world data analysis, to help advance equity in medical research for women’s health issues,” said Dr. Dodson.  “Through this appointment, I look forward to contributing to the society’s work as part of Astellas’ shared commitment to transform women’s health.”

“Studying and understanding the significant differences in women and men in medical research is as crucial as ever,” said John J. Seng, chair of the SWHR Board and founder and CEO of Spectrum Science Communications. “I’m glad to know that Dr. Dodson will support the SWHR mission to help keep the spotlight on sex differences and advocating for women’s health in scientific research and policy.”

###

 

About SWHR

The Society for Women’s Health Research (SWHR®), is a national non-profit based in Washington D.C. that is widely recognized as the thought-leader in promoting research on biological differences in disease. SWHR is dedicated to transforming women’s health through science, advocacy, and education. Founded in 1990 by a group of physicians, medical researchers and health advocates, SWHR aims to bring attention to the variety of diseases and conditions that disproportionately or predominately affect women. For more information, please visit www.swhrdev.wpengine.com. Follow us on Twitter at @SWHR.

 

About Astellas

Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. For more information on Astellas, please visit our website at www.astellas.us. You can also follow us on Twitter at @AstellasUS. Visit our Facebook page at www.facebook.com/AstellasUS.

Washington, D.C.  (September 22, 2015) — The Society for Women’s Health Research (SWHR®) is excited to announce the appointment of a new member to its Board of Directors. Joining the Board is Shontelle Dodson, PharmD, vice president of Medical Excellence within Medical Affairs, Global, at Astellas Pharma Inc.

“We are delighted to welcome Dr. Dodson to our Board of Directors,” said Phyllis Greenberger, MSW, president and CEO of SWHR. “Her extensive experience in the pharmaceutical and health care industries, clinical research, and real world data analysis and her involvement in developing and implementing medical and managed access strategies to support patient health will be a great asset to advancing our mission to transform women’s health.”

Dr. Dodson has extensive clinical and research experience in the healthcare and pharmaceutical industries.  After several years of service in direct patient care at the Department of Veterans Affairs, Dr. Dodson spent 11 years at Pfizer, Inc., in various leadership roles, serving as the leader of the U.S. Viagra Medical Team and as senior director, group leader supporting the Urology and Respiratory franchise.

Following her work with Pfizer, Dr. Dodson served as vice president, Medical Affairs at GTx, Inc., where she led the Phase 3 clinical development of a selective androgen receptor modulator for the prevention and treatment of muscle wasting in patients with cancer, including key economic and health outcomes assessments to support product utilization and valuation.

Under her leadership at Astellas, the Health Economics and Clinical Outcomes Research team in the Americas has pioneered multiple, innovative real world data projects, including two national registries in prostate cancer and overactive bladder, as well as partnered research with leading managed care and academic organizations.

She has received multiple awards for leadership and innovation during her career, including the National Healthcare Business Women’s Association Rising Star.  Dr. Dodson holds a doctor of pharmacy degree from Mercer University School of Pharmacy and completed a postdoctoral residency at the Department of Veterans Affairs Medical Center in Nashville, Tennessee.

“I am honored to join the Society for Women’s Health Research Board of Directors to lend my expertise, especially in clinical research and real world data analysis, to help advance equity in medical research for women’s health issues,” said Dr. Dodson.  “Through this appointment, I look forward to contributing to the society’s work as part of Astellas’ shared commitment to transform women’s health.”

“Studying and understanding the significant differences in women and men in medical research is as crucial as ever,” said John J. Seng, chair of the SWHR Board and founder and CEO of Spectrum Science Communications. “I’m glad to know that Dr. Dodson will support the SWHR mission to help keep the spotlight on sex differences and advocating for women’s health in scientific research and policy.”

###

 

About SWHR

The Society for Women’s Health Research (SWHR®), is a national non-profit based in Washington D.C. that is widely recognized as the thought-leader in promoting research on biological differences in disease. SWHR is dedicated to transforming women’s health through science, advocacy, and education. Founded in 1990 by a group of physicians, medical researchers and health advocates, SWHR aims to bring attention to the variety of diseases and conditions that disproportionately or predominately affect women. For more information, please visit www.swhrdev.wpengine.com. Follow us on Twitter at @SWHR.

 

About Astellas

Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. For more information on Astellas, please visit our website at www.astellas.us. You can also follow us on Twitter at @AstellasUS. Visit our Facebook page at www.facebook.com/AstellasUS.